Financial Ratios

CAPSUGEL HEALTHCARE LTD.

NSE : NABSE : 506887ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : MNC
BSE77.750 (0 %)
PREV CLOSE ( ) 77.75
OPEN PRICE ( ) 79.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )75.70 79.85
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2017Mar2016Mar2015Mar2014Mar2013
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.79-0.86-0.62-0.94-0.04
   CEPS(Rs)-0.34-0.29-0.01-0.410.45
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)4.843.264.124.575.33
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-13.83-6.99-0.13-11.34-4.42
   EBIT Margin(%)-22.05-19.12-13.03-24.26-1.18
   Pre Tax Margin(%)-22.44-20.01-13.21-24.26-1.18
   PAT Margin (%)-22.44-20.01-13.21-24.26-1.18
   Cash Profit Margin (%)-9.54-6.73-0.14-10.6412.05
Performance Ratios
   ROA(%)-10.88-9.50-7.65-11.98-0.54
   ROE(%)-20.90-23.40-14.42-19.39-0.94
   ROCE(%)-15.72-16.30-13.53-19.39-0.94
   Asset Turnover(x)0.480.470.580.490.46
   Sales/Fixed Asset(x)0.550.570.640.560.55
   Working Capital/Sales(x)2.303.11-55.01-13.7929.83
Efficiency Ratios
   Fixed Capital/Sales(x)1.801.761.571.771.80
   Receivable days103.14104.2095.94116.31109.46
   Inventory Days97.4897.9088.9389.9880.69
   Payable days147.66186.04187.73227.57282.81
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)3.141.932.302.822.91
   EV/Core EBITDA(x)-22.10-29.934640.83-24.07-61.21
   EV/EBIT(x)-12.81-9.13-16.05-10.55-224.86
   EV/CE(x)1.550.781.141.271.22
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-3.41-8.2424.227.1440.85
   Core EBITDA Growth(%)-112.570.00100.53-163.4382.07
   EBIT Growth(%)-11.91-35.5633.27-2106.9196.69
   PAT Growth(%)-8.77-39.9632.34-2106.9196.92
   EPS Growth(%)8.23-39.9634.39-2020.2496.93
Financial Stability Ratios
   Total Debt/Equity(x)0.080.140.100.000.00
   Current Ratio(x)2.451.350.980.911.04
   Quick Ratio(x)1.501.090.650.580.72
   Interest Cover(x)-57.28-21.33-71.31
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.